HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 94 filers reported holding HERON THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.27 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $189,357 | -58.7% | 183,842 | -53.5% | 0.00% | – |
| Q2 2023 | $458,298 | -11.2% | 395,084 | +15.6% | 0.00% | – |
| Q1 2023 | $516,231 | -47.4% | 341,875 | -12.9% | 0.00% | – |
| Q4 2022 | $981,318 | -40.8% | 392,527 | -0.0% | 0.00% | – |
| Q3 2022 | $1,657,000 | +105.3% | 392,677 | +35.7% | 0.00% | – |
| Q2 2022 | $807,000 | -76.1% | 289,288 | -50.9% | 0.00% | – |
| Q1 2022 | $3,372,000 | -30.7% | 589,566 | +10.6% | 0.00% | – |
| Q4 2021 | $4,866,000 | +117.8% | 532,976 | +155.0% | 0.00% | – |
| Q3 2021 | $2,234,000 | -20.7% | 209,029 | +15.2% | 0.00% | – |
| Q2 2021 | $2,817,000 | -56.9% | 181,520 | -55.0% | 0.00% | – |
| Q1 2021 | $6,539,000 | +29.0% | 403,355 | +68.4% | 0.00% | – |
| Q4 2020 | $5,070,000 | +347.9% | 239,554 | +213.7% | 0.00% | – |
| Q3 2020 | $1,132,000 | -63.1% | 76,371 | -63.4% | 0.00% | -100.0% |
| Q2 2020 | $3,071,000 | -53.3% | 208,767 | -62.8% | 0.00% | -50.0% |
| Q1 2020 | $6,583,000 | +19.7% | 560,755 | +139.6% | 0.00% | 0.0% |
| Q4 2019 | $5,501,000 | -13.9% | 234,069 | -32.2% | 0.00% | 0.0% |
| Q3 2019 | $6,386,000 | -64.2% | 345,229 | -64.0% | 0.00% | 0.0% |
| Q2 2019 | $17,817,000 | -30.0% | 958,391 | -8.0% | 0.00% | -81.8% |
| Q1 2019 | $25,453,000 | +444.8% | 1,041,428 | +478.2% | 0.01% | +1000.0% |
| Q4 2018 | $4,672,000 | -1.7% | 180,107 | +19.9% | 0.00% | 0.0% |
| Q3 2018 | $4,754,000 | -70.4% | 150,197 | -63.6% | 0.00% | -80.0% |
| Q2 2018 | $16,034,000 | -9.0% | 412,736 | -35.3% | 0.01% | -16.7% |
| Q1 2018 | $17,615,000 | +115.3% | 638,225 | +41.2% | 0.01% | +100.0% |
| Q4 2017 | $8,183,000 | +4.8% | 452,082 | -6.5% | 0.00% | 0.0% |
| Q3 2017 | $7,805,000 | -25.7% | 483,327 | -36.3% | 0.00% | -25.0% |
| Q2 2017 | $10,507,000 | +433.1% | 758,644 | +477.4% | 0.00% | +300.0% |
| Q1 2017 | $1,971,000 | -90.2% | 131,400 | -91.4% | 0.00% | -90.0% |
| Q4 2016 | $20,089,000 | +33.2% | 1,533,527 | +75.2% | 0.01% | +42.9% |
| Q3 2016 | $15,082,000 | +49.7% | 875,282 | +56.8% | 0.01% | +16.7% |
| Q2 2016 | $10,076,000 | +30.0% | 558,219 | +36.8% | 0.01% | +50.0% |
| Q1 2016 | $7,749,000 | -47.8% | 408,094 | -26.6% | 0.00% | -42.9% |
| Q4 2015 | $14,840,000 | -67.7% | 555,832 | -70.5% | 0.01% | -65.0% |
| Q3 2015 | $45,992,000 | +25.1% | 1,884,888 | +59.8% | 0.02% | +25.0% |
| Q2 2015 | $36,750,000 | +320.3% | 1,179,419 | +96.3% | 0.02% | +300.0% |
| Q1 2015 | $8,743,000 | +1800.7% | 600,901 | +1215.5% | 0.00% | – |
| Q4 2014 | $460,000 | -90.2% | 45,678 | -88.0% | 0.00% | -100.0% |
| Q2 2014 | $4,681,000 | – | 379,946 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |